SCHEMBL693373

SCHEMBL693373

O=C(Nc1c(F)cccc1F)c1cn[nH]n1

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.50
CYP3A4 P08684 1/20 0.50
CYP2C9 P11712 1/20 0.50
ALOX15 P16050 1/20 0.50
CYP2C19 P33261 1/20 0.50
KIT P10721 1/20 0.43
AKR1C3 P42330 3/20 0.43
ALDH1A1 P00352 2/20 0.42
KMT2A Q03164 3/20 0.41
MAPK14 Q16539 1/20 0.40
NPY5R Q15761 1/20 0.40
MME P08473 2/20 0.39
IDO1 P14902 1/20 0.39
PDE4D Q08499 1/20 0.39
MEN1 O00255 2/20 0.38
NLRP3 Q96P20 1/20 0.38
MAOA P21397 1/20 0.38
MAOB P27338 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL561714 0.76 ALDH1A1 (0.47) CYP1A2CYP3A4CYP2C9CYP2C19ALDH1A1
SCHEMBL17136102 0.72 HDAC6 (0.57)
SCHEMBL561358 0.72 ALDH1A1 (0.46) ALDH1A1KMT2AMAPK14NPY5RPDE4D
SCHEMBL2727042 0.72 SMN1; SMN2 (0.50) ALDH1A1KMT2ANPY5R
SCHEMBL31133474 0.71 POLB (0.46) ALDH1A1KMT2AMAPK14NPY5RPDE4D
SCHEMBL38658970 0.71 ADORA2A (0.43) ALDH1A1KMT2ANPY5RMEN1MAOA
SCHEMBL23808915 0.70 KMT2A (0.63) ALDH1A1KMT2AMEN1MAOAMAOB
SCHEMBL20302477 0.70 P2RX7 (0.56) ALDH1A1KMT2ANPY5R
SCHEMBL28183890 0.69 PIM1 (0.47) ALDH1A1KMT2ANPY5RPDE4D
SCHEMBL24059154 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2421834-A1 PYRAZOLE AND TRIAZOLE CARBOXAMIDES AS CRAC CHANNEL INHIBITORS Glaxo Group Limited (GB) 2012-02-29 EP claimed
EP-2421834-A1 PYRAZOLE AND TRIAZOLE CARBOXAMIDES AS CRAC CHANNEL INHIBITORS Glaxo Group Limited (GB) 2012-02-29 EP disclosed